NAMS
NewAmsterdam Pharma Company N.V.
$38.27
+$0.56(+1.49%)
70
Overall
50
Value
91
Tech
--
Quality
Market Cap
$4.41B
Volume
1.46M
52W Range
$14.06 - $41.47
Target Price
$45.92
EPS Estimates Overview
| Current Quarter | $-0.4 | Next Quarter | $-0.44 |
| Current Year | $-1.6 | Next Year | $-2.01 |
| QoQ Growth | -10.0% | YoY Growth | -25.6% |
| 3Y EPS CAGR | -63.3% | Target Price | $45.92 |
| Consensus | Buy | Upside | +20.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $38.27 | +1.5% | 1.46M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW